Why the world needs an independent evidence panel for AMR now

Dame Sally Davies

The world needs to tackle AMR to ensure the security of human health, our food chain, our environment and our economies. Unchecked, AMR will drive life expectancy back to medieval levels.


The best way to mitigate AMR is through global governance that drives action based on evidence across the whole ‘One Health’ spectrum. We need a productive Independent Panel for Evidence for Action (IPEA) on AMR. It needs to show how infections resistant to treatment — bacteria, fungi, viruses and more — are spreading and how resistance moves between humans, animals, plants and the environment through multiple transmission pathways, as well as driving action.

IPEA must be practical, focused and urgent

IPEA needs a focus on high-burden countries, complementing other work without duplicating or commissioning research. It needs to share interventions that work, their settings and how to adapt, scale and deliver in practice, building on experience on the ground — not producing more reports about the problem. To deliver, IPEA needs balanced expertise from One Health, with strong representation of independent scientists from the countries carrying the greatest AMR burden.

The world can make progress, and we look to the UN to lead now. There is no time to wait.

IPEA was first recommended to the UN in 2018, so why are we still waiting? This must be member-state led. WHO, FAO, UNEP and WOAH are the right bodies to make it happen. With a panel structured as above, alongside a detailed roadmap toward full independence, work can start now.

Launch IPEA in Nigeria this December

The fourth global ministerial meeting on AMR takes place in Nigeria this December — a perfect moment to launch the IPEA with plans for outputs through to the 2030 UN high-level meeting.

AMR spreads through trade, travel, health, food systems and the environment. Evidence for action must be freely available to governments, industry, professionals and the public alike. The world can make progress, and we look to the UN to lead now. There is no time to wait.

More from AMR & Infectious Diseases